In February 2009, Andrew Witty is reflected in his vision of Big Pharma as a catalyst for change that are focused on two key issues: 1) the promotion of innovation for products, treatment and prevention of neglected tropical diseases, and 2) to improve access to medicines in the world's poorest countries. He announced the creation of "pharmaceutical patent pool", and thought it was the right strategy to deliver on two key issues. "Hide
by Michael Rose, Chander Sehgal Source: Richard Ivey School of Business Foundation 20 pages. Publication Date: March 8, 2011. Prod. #: W10017-PDF-ENG
Related Case Solutions & Analyses:
University Health Network (UHN): The MOE-MAR Initiative
Netflix
Oncidium Business Consulting (A2)
Sullivans Flooring Concept
Auditor Liability in Canada (B)
Melco Entertainment Limited
Meridco Magnesium: International Technology Transfer
The Professor Selects a Portfolio
Robert Mondavi Corp.: Caliterra (B)
Ben & Jerrys–Japan
